Daclatasvir, sofosbuvir, and ribavirin for hepatitis C virus genotype 3 and advanced liver disease: A randomized phase III study (ALLY-3+) Journal Articles Refereed uri icon

Overview

Authors

Published in

  • Hepatology

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1002/hep.28473

Additional Document Info

Parent Title

  • HEPATOLOGY

Volume

  • 63

Issue

  • 5

Publisher

  • WB Saunders Co